Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

The landscape of Alzheimer’s research is evolving as scientists ... to viral-based approaches could pave the way for new treatment options that are more accessible and effective.

The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatment options is the kind of advancement we’ve all been waiting ...

The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatment options is the kind of advancement we’ve all been waiting ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Having multiple treatment options is the kind of advancement we’ve all been waiting for." Research this year has helped move Alzheimer’s blood tests closer to being used in physicians' offices.

Posdinemab, an investigational monoclonal antibody, works by targeting and neutralizing Alzheimer disease-specific ... the urgent unmet need for new treatment options for the millions living ...

This raises the possibility of HMTM becoming the third consecutive Alzheimer's treatment to face NHS rejection ... as accurate as the current diagnosis options and works by measuring levels ...

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...